1.

Hepatoprotective Effects of Silymarin on Liver Injury via Irisin Upregulation and Oxidative Stress Reduction in Rats with Type 2 Diabetes

دوره 44، شماره 2، خرداد 2019، صفحه 108-117
Nejat Kheiripour؛ Jamshid Karimi؛ Iraj Khodadadi؛ Heidar Tavilani؛ Mohammad Taghi Goodarzi؛ Mohammad Hashemnia

2.

Silymarin Administration Attenuates Cirrhotic-induced Cardiac Abnormality in the Rats: A Possible Role of β1-adrenergic Receptors and L-type Voltage-Dependent Calcium Channels

دوره 47، شماره 4، مهر 2022، صفحه 367-378
Gholamreza Bayat؛ Roham Mazloom؛ Seyed Ali Hashemi؛ Khalil Pourkhalili؛ Parviz Fallah؛ Alireza Shams؛ Parvaneh Esmaeili؛ Azadeh Khalili

3.

Silymarin’s Potential in Countering Drug-induced Cardiotoxicity, Nephrotoxicity, and Hepatotoxicity: A Narrative Review

دوره 10، شماره 1، خرداد 2024، صفحه 15-24
Ava Karimian؛ Laleh Mahmoudi

4.

The Effect of Oral Administration of Silymarin on Serum Levels of Tumor Necrosis Factor-α and Interleukin-1ß in Patients with Rheumatoid Arthritis

دوره 19، شماره 4، اسفند 2022، صفحه 427-435
Mehrdad Shavandi؛ Yasaman Yazdani؛ Shirin Asar؛ Arash Mohammadi؛ Ehsan Mohammadi-noori؛ Amir Kiani

5.

The Influence of Iron Loading and Iron Chelation on the Proliferation and Telomerase Activity of Human Peripheral Blood Mononuclear Cells

دوره 6، شماره 1، خرداد 2009، صفحه 33-39
Bahram Bagherpour؛ Marjan Gharagozloo؛ Behjat Moayedi


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب